Organisation paid for research Program year 2025 Source: CMS Open Payments

Reserka LLC

Neither a doctor nor a teaching hospital

Research payments

$612,467

52 payments

Through program year 2025, Reserka LLC is reported as receiving $612,467 in research payments, across 52 payments.

By program year

2 rows

Year	Kind	Amount	Payments
2025	Research	$89,287	19
2024	Research	$523,180	33

Breakdown

Who paid Research payments · program years 2024–2025

Radiometer America, Inc $493,552 30 payments
Tolmar, Inc. $95,426 21 payments
Eli Lilly and Company $23,490 1 payment

Studies the money was for Research payments · program years 2024–2025

ABL90 FLEX PLUS Method Comparison Study for ctBil and FHbF in Neonatal arterial, venous, and capillary whole blood $279,723 16 payments
ABL90 FLEX PLUS Method Comparison study ADULTS: ARTERIAL, VENOUS AND CAPILLARY BLOOD $213,828 14 payments
Tol-Clar-20024 $65,797 18 payments
A Phase 4 Study to Evaluate Adrenal Function in Hypogonadal Men Treated With JATENZO for 12 Months $29,628 3 payments
An Adaptive, Dose-Ranging, Phase 2 Study of Eltrekibart Given Alone Or in Combination With Mirikizumab for the Treatment of Adult Patients With Moderately to Severely Active Ulcerative Colitis $23,490 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.